2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one has been researched along with Uremia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Deyn, PP; Macdonald, RL | 1 |
1 other study(ies) available for 2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one and Uremia
Article | Year |
---|---|
Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture.
Topics: Animals; Brain Chemistry; Cells, Cultured; Creatinine; Drug Synergism; GABA Antagonists; Glycine; Guanidine; Guanidines; Methylguanidine; Mice; Neurons; Pyrazoles; Spinal Cord; Succinates; Uremia | 1990 |